Paya Carlos V

CIK 00016062445 companiesSEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001606244

Recent Transactions

50 trades

Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2025-06-12+15,372→ 15,372 total
Award
Vaxcyte, Inc.$PCVX
Common Stock
2025-06-12+3,041→ 4,591 total
Award
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2025-05-15+19,582→ 19,582 total
Gift
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2024-12-09−7,250→ 0 total
Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2024-12-09+7,250→ 7,250 total
Gift
Vaxcyte, Inc.$PCVX
Common Stock
2024-12-06−2,500→ 1,550 total
Award
Vaxcyte, Inc.$PCVX
Common Stock
2024-12-06+2,500→ 5,625 total
Award
Vaxcyte, Inc.$PCVX
Common Stock
2024-06-06+1,550→ 4,050 total
Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2024-06-06+7,250→ 7,250 total
Gift
Vaxcyte, Inc.$PCVX
Common Stock
2023-11-09−3,125→ 2,500 total
Gift
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2023-11-09−30,000→ 0 total
Gift
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2023-11-09−18,750→ 0 total
Award
Vaxcyte, Inc.$PCVX
Common Stock
2023-11-09+3,125→ 3,125 total
Gift
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2023-11-09+18,750→ 18,750 total
Gift
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2023-11-09+15,000→ 15,000 total
Gift
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2023-11-09+30,000→ 30,000 total
Gift
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2023-11-09−15,000→ 0 total
Award
STANDARD BIOTOOLS INC.$LAB
Common Stock
2023-06-14+26,376→ 126,844 total
Award
STANDARD BIOTOOLS INC.$LAB
Stock Option (Right to Buy)
2023-06-14+35,380→ 35,380 total
Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2023-06-13+15,000→ 15,000 total
Award
Vaxcyte, Inc.$PCVX
Common Stock
2023-06-13+2,500→ 5,625 total
Award
STANDARD BIOTOOLS INC.$LAB
Common Stock
2022-06-15+30,914→ 100,468 total
Award
STANDARD BIOTOOLS INC.$LAB
Stock Option (Right to Buy)
2022-06-15+42,571→ 42,571 total
Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2022-06-01+18,750→ 18,750 total
Award
Vaxcyte, Inc.$PCVX
Common Stock
2022-06-01+3,125→ 3,125 total
Award
Vaxcyte, Inc.$PCVX
Stock Option (Right to Buy)
2021-10-27+30,000→ 30,000 total
Award
STANDARD BIOTOOLS INC.$LAB
Common Stock
2021-05-25+10,342→ 69,554 total
Award
STANDARD BIOTOOLS INC.$LAB
Stock Option (Right to Buy)
2021-05-25+15,402→ 15,402 total
Exercise/Conversion
STANDARD BIOTOOLS INC.$LAB
Restricted Stock Units
2021-03-23−2,500→ 0 total
Exercise/Conversion
STANDARD BIOTOOLS INC.$LAB
Common Stock
2021-03-23+2,500→ 59,212 total
Sale
Keenova Therapeutics plc
Ordinary Shares
2021-03-12$0.40/sh−16,614→ 0 total
Award
STANDARD BIOTOOLS INC.$LAB
Stock Option (Right to Buy)
2020-06-23+20,993→ 20,993 total
Award
STANDARD BIOTOOLS INC.$LAB
Common Stock
2020-06-23+13,369→ 56,712 total
Tax Payment
Keenova Therapeutics plc
Ordinary Shares
2020-05-13$2.96/sh−14,735→ 16,614 total
Exercise/Conversion
STANDARD BIOTOOLS INC.$LAB
Restricted Stock Units
2020-03-23−2,500→ 2,500 total
Exercise/Conversion
STANDARD BIOTOOLS INC.$LAB
Common Stock
2020-03-23+2,500→ 43,343 total
Award
STANDARD BIOTOOLS INC.$LAB
Stock Option (Right to Buy)
2019-06-03+6,796→ 6,796 total
Award
STANDARD BIOTOOLS INC.$LAB
Common Stock
2019-06-03+3,987→ 40,843 total
Award
Keenova Therapeutics plc
Ordinary Shares
2019-05-22+31,349→ 31,349 total
Disposition to Issuer
IMMUNE DESIGN CORP.
Stock Option (Rt to Buy)
2019-04-02−61,161→ 0 total
Disposition to Issuer
IMMUNE DESIGN CORP.
Common Stock
2019-04-02$5.85/sh−35,576→ 0 total
Disposition to Issuer
IMMUNE DESIGN CORP.
Restricted Stock Units
2019-04-02−121,000→ 0 total
Disposition to Issuer
IMMUNE DESIGN CORP.
Stock Option (Rt to Buy)
2019-04-02−195,289→ 0 total
Disposition to Issuer
IMMUNE DESIGN CORP.
Stock Option (Rt to Buy)
2019-04-02−244,648→ 0 total
Disposition to Issuer
IMMUNE DESIGN CORP.
Stock Option (Rt to Buy)
2019-04-02−67,277→ 0 total
Disposition to Issuer
IMMUNE DESIGN CORP.
Stock Option (Rt to Buy)
2019-04-02−216,500→ 0 total
Disposition to Issuer
IMMUNE DESIGN CORP.
Stock Option (Rt to Buy)
2019-04-02−175,000→ 0 total
Disposition to Issuer
IMMUNE DESIGN CORP.
Stock Option (Rt to Buy)
2019-04-02−263,009→ 0 total
Disposition to Issuer
IMMUNE DESIGN CORP.
Stock Option (Rt to Buy)
2019-04-02−293,000→ 0 total
Exercise/Conversion
STANDARD BIOTOOLS INC.$LAB
Common Stock
2019-03-23+2,500→ 36,856 total

Companies

Recent Filings

Address

C/O IMMUNE DESIGN CORP. 1616 EASTLAKE AVE. E., SUITE 310

SEATTLE, WA, 98102

View on SEC.gov